Trinity Biotech plc (TRIB) Sales and Gross margin improved amid covid-19 outbreak
Trinity Biotech plc (Nasdaq: TRIB) revealed its financial results for the quarter ended September 30, 2020. Revenue of the clinical Laboratory surged from $20.7m to $29.9m for the year, a rise of 45%. All of the company’s product lines recovered considerably from fiscal second quarter2020 levels during the quarter, revealing the most extreme effects of […]
